Table 5.
Multivariate analyses of various CKD-MBD-related factors associated with serum fraction of human non-mercaptalbumin [f(HNA)].
| Model 1 | Model 2 | |||
|---|---|---|---|---|
| β | p | β | p | |
| Age | 0.310 | <0.001 | 0.276 | 0.002 |
| Gender | −0.038 | 0.673 | 0.001 | 0.993 |
| eGFR | −0.285 | 0.009 | −0.338 | 0.004 |
| Corrected calcium | 0.079 | 0.458 | −0.015 | 0.895 |
| Phosphate | 0.060 | 0.566 | 0.023 | 0.848 |
| Intact-PTH | 0.218 | 0.049 | — | — |
| Fibroblast growth factor-23 | — | — | 0.084 | 0.476 |
| 1,25(OH)2D | −0.178 | 0.040 | −0.176 | 0.049 |
| R2 | 0.339 (p < 0.001) | 0.317 (p < 0.001) | ||
CKD-MBD; chronic kidney disease and mineral and bone disorder, eGFR: estimated glomerular filtration rate, and PTH: parathyroid hormone, 1,25(OH)2D: 1,25-dihydroxyvitamin D, β: standardized correlation coefficient, R2: multiple coefficient of determination.